Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Investors Might Hold CrowdStrike Ahead of Earnings

By Chris Lau, InvestorPlace Contributor

CRWD stock faced unusual selling pressure on no news, even though the cybersecurity firm is expected to grow 10% compounded annually.

It Looks Like Volatile Nikola Stock May Not Move Meaningfully Until 2024

By Chris Lau, InvestorPlace Contributor

Nikola stock may face continued selling pressure after posting only $36,000 in revenue and promising a hot product later down the road.

Inovio Still Has a Chance to Break Out in a Big Way

By Chris Lau, InvestorPlace Contributor

Inovio did not get the government funding or pre-orders like its competitors did, so if it happens later, INO stock will respond positively

7 AI Stocks to Buy for the Increasing Digitization of Healthcare

By Chris Lau, InvestorPlace Contributor

Healthcare digitization accelerated dramatically in response to the coronavirus pandemic, raising prospects for these AI stocks to buy.

As Plug Power Stock Surges, Take Profits Before It Falls to Earth

By Chris Lau, InvestorPlace Contributor

Brace for a wild ride in Plug stock after the spectacular run-up and the predictable profit-taking that followed

Load More